Dr Martens PLC
LSE:DOCS
Dr Martens PLC
Total Equity
Dr Martens PLC
Total Equity Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Dr Martens PLC
LSE:DOCS
|
Total Equity
£366.4m
|
CAGR 3-Years
4%
|
CAGR 5-Years
39%
|
CAGR 10-Years
N/A
|
|
|
Birkenstock Holding PLC
NYSE:BIRK
|
Total Equity
€2.6B
|
CAGR 3-Years
4%
|
CAGR 5-Years
45%
|
CAGR 10-Years
N/A
|
|
Dr Martens PLC
Glance View
Dr. Martens Plc engages in the manufacture and sale of footwear products. The firm operates through three reporting segments: Europe, the Middle East and Africa (EMEA), Americas and Americas and Asia-Pacific (APAC). Its product categories include Originals, Fusion, Kids, Casual and Accessories. The Originals category comprises boots, shoes and loafers and also included within the Originals category is the Made in England range. The Fusion category comprises platform boots and shoes, sandals, heels and refined take downs of the Originals. Within the Kids category is the mini-me range, which includes Originals, Fusion and Casual collections. The company offers various accessories, such as shoe care, laces and socks, leather bags and small leather items. The company operates in over 60 countries globally, through a range of modes: directly operated stores and ecommerce sites, wholesale partners and distributors.
See Also
What is Dr Martens PLC's Total Equity?
Total Equity
366.4m
GBP
Based on the financial report for Mar 30, 2025, Dr Martens PLC's Total Equity amounts to 366.4m GBP.
What is Dr Martens PLC's Total Equity growth rate?
Total Equity CAGR 5Y
39%
Over the last year, the Total Equity growth was 0%. The average annual Total Equity growth rates for Dr Martens PLC have been 4% over the past three years , 39% over the past five years .
